Aimovig

Erenumab-aooe · Amgen, Inc
PRESCRIPTION ONLY (USA)

Aimovig ingredients

Active ingredientStrength
Erenumab70 mg/mL, 140 mg/mL

What Aimovig is used for

Aimovig is a specialist medicine. Its approved uses are listed on the official FDA label below.

Key facts

Brand
Aimovig
Generic name
Erenumab-aooe
Made by
Amgen, Inc
Forms
Injection, Injection, Solution
Given
Subcutaneous
FDA approval
Biologic licence (BLA) BLA761077
On the US market since
2018

Official information

In India

Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.

Common questions

What is Aimovig?

Aimovig (Erenumab-aooe) is a specialist medicine made by Amgen, Inc, approved by the US FDA.

What are the ingredients of Aimovig?

Aimovig contains Erenumab (70 mg/mL, 140 mg/mL).

From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.

← All specialty medicines, USA

For information only, not medical advice. This page is a plain-language summary written from standard prescribing information and the public guides linked below. Brands sometimes change their formula, so always check the composition printed on the pack. Doses here are typical adult doses; yours may differ. Do not start, stop or change a medicine without your doctor or pharmacist, and keep all medicines away from children. In an emergency, call 112 (India) or your local emergency number.